Targeting ER stress/IRE1α has thus been proposed for its potential in countering obesity and obesity-related metabolic disorders including insulin resistance and type 2 diabetes (Hetz et al., 2013; Marciniak et al., 2022). The gene discussed is ERN1; the disease is obesity due to melanocortin 4 receptor deficiency.